240 related articles for article (PubMed ID: 12553024)
1. Inhibition of endometrial carcinoma cell growth using antisense estrogen receptor oligodeoxyribonucleotides.
Taylor AH; al-Azzawi F; Pringle JH; Bell SC
Anticancer Res; 2002; 22(6C):3993-4003. PubMed ID: 12553024
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of estrogen receptor-alpha in the endometrial carcinoma cell line Ishikawa: inhibition of growth and angiogenic factors.
Ali SH; O'Donnell AL; Mohamed S; Mousa S; Dandona P
Gynecol Oncol; 2004 Dec; 95(3):637-45. PubMed ID: 15581976
[TBL] [Abstract][Full Text] [Related]
3. [Modulation and function of estrogen receptor isoforms alpha and beta in endometrial carcinoma cells].
Zhang Y; Liao QP; Yu L; Zhao J; Chen CL
Zhonghua Fu Chan Ke Za Zhi; 2005 Aug; 40(8):558-61. PubMed ID: 16202298
[TBL] [Abstract][Full Text] [Related]
4. A rat endometrial cell line (R1-49E1) expressing estrogen receptor-alpha regulated by the tet-off system.
Castro I; Arias J; Flores H; BarrĂ³n A
Arch Med Res; 2005; 36(4):331-8. PubMed ID: 15950070
[TBL] [Abstract][Full Text] [Related]
5. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium.
Shabani N; Mylonas I; Jeschke U; Thaqi A; Kuhn C; Puchner T; Friese K
Anticancer Res; 2007; 27(4A):2027-33. PubMed ID: 17649817
[TBL] [Abstract][Full Text] [Related]
6. Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study.
Wilder JL; Shajahan S; Khattar NH; Wilder DM; Yin J; Rushing RS; Beaven R; Kaetzel C; Ueland FR; van Nagell JR; Kryscio RJ; Lele SM
Gynecol Oncol; 2004 Feb; 92(2):553-8. PubMed ID: 14766247
[TBL] [Abstract][Full Text] [Related]
7. [Study on the modulation of estrogen receptor isoforms alpha in endometrial carcinoma cells using antisense oligodeoxyribonucleotides].
Zhang Y; Liao QP; Yu L; Chen CL; Zhao J
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Apr; 37(2):155-8. PubMed ID: 15841144
[TBL] [Abstract][Full Text] [Related]
8. Estrogen-receptor-dependent regulation of telomerase activity in human endometrial cancer cell lines.
Boggess JF; Zhou C; Bae-Jump VL; Gehrig PA; Whang YE
Gynecol Oncol; 2006 Nov; 103(2):417-24. PubMed ID: 16690106
[TBL] [Abstract][Full Text] [Related]
9. Normal and malignant human endometrium express immunohistochemically estrogen receptor alpha (ER-alpha), estrogen receptor beta (ER-beta) and progesterone receptor (PR).
Mylonas I; Jeschke U; Shabani N; Kuhn C; Kriegel S; Kupka MS; Friese K
Anticancer Res; 2005; 25(3A):1679-86. PubMed ID: 16033082
[TBL] [Abstract][Full Text] [Related]
10. Specific inhibition of estrogen receptor alpha function by antisense oligodeoxyribonucleotides.
Taylor AH; Pringle JH; Bell SC; Al-Azzawi F
Antisense Nucleic Acid Drug Dev; 2001 Aug; 11(4):219-31. PubMed ID: 11572599
[TBL] [Abstract][Full Text] [Related]
11. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.
Kinoshita Y; Chen S
Cancer Res; 2003 Jul; 63(13):3546-55. PubMed ID: 12839940
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells.
Bhat KP; Pezzuto JM
Cancer Res; 2001 Aug; 61(16):6137-44. PubMed ID: 11507064
[TBL] [Abstract][Full Text] [Related]
13. [Overexpression of estrogen receptor-related receptor alpha can stimulate estrogen receptor negative endometrial cancer cell proliferation].
Sun PM; Wei LH; Gao M; Wang JL; Zhao LJ; Wang DP; Zhang JX
Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):408-11. PubMed ID: 17697604
[TBL] [Abstract][Full Text] [Related]
14. [Role of estrogen receptor isoforms in the pathogenesis and treatment of endometrial cancer].
Hanstein B; Beckmann MW; Bender HG
Zentralbl Gynakol; 2002 Jan; 124(1):17-9. PubMed ID: 11873309
[TBL] [Abstract][Full Text] [Related]
15. Well-differentiated endometrial adenocarcinomas and poorly differentiated mixed mullerian tumors have altered ER and PR isoform expression.
Jazaeri AA; Nunes KJ; Dalton MS; Xu M; Shupnik MA; Rice LW
Oncogene; 2001 Oct; 20(47):6965-9. PubMed ID: 11687977
[TBL] [Abstract][Full Text] [Related]
16. Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells.
Liu ZJ; Zhu BT
J Steroid Biochem Mol Biol; 2004 Mar; 88(3):265-75. PubMed ID: 15120420
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.
Gougelet A; Bouclier C; Marsaud V; Maillard S; Mueller SO; Korach KS; Renoir JM
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):71-81. PubMed ID: 15862952
[TBL] [Abstract][Full Text] [Related]
18. Oestrogen receptor beta expression and depth of myometrial invasion in human endometrial cancer.
Takama F; Kanuma T; Wang D; Kagami I; Mizunuma H
Br J Cancer; 2001 Feb; 84(4):545-9. PubMed ID: 11207052
[TBL] [Abstract][Full Text] [Related]
19. The cis decoy against the estrogen response element suppresses breast cancer cells via target disrupting c-fos not mitogen-activated protein kinase activity.
Wang LH; Yang XY; Zhang X; Mihalic K; Xiao W; Farrar WL
Cancer Res; 2003 May; 63(9):2046-51. PubMed ID: 12727818
[TBL] [Abstract][Full Text] [Related]
20. The granulin-epithelin precursor is a steroid-regulated growth factor in endometrial cancer.
Jones MB; Houwink AP; Freeman BK; Greenwood TM; Lafky JM; Lingle WL; Berchuck A; Maxwell GL; Podratz KC; Maihle NJ
J Soc Gynecol Investig; 2006 May; 13(4):304-11. PubMed ID: 16697948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]